COVID - 19 - Critical sanitary supplies - Determination, manufacturing, commercialization and promotion
Critical sanitary supplies – Determination, manufacturing, commercialization and promotion
Joint resolution 1/2020
By Joint Resolution No. 1/2020 of the Ministry of Health and Ministry of Productive Development, published on March 20, 2020, a series of health supplies were established as "necessary and critical" to mitigate the spread of COVID-19 and for its therapeutic and curative treatment. The list of supplies includes equipment such as ventilators, infusion pumps, hospital beds, oximeters, ultrasound scanners, aspirators, oxygen tubes and thermometers; protection elements such as chinstraps, camisoles, gloves, goggles and gel alcohol; and medications such as amoxicillin, azithromycin, cephalexin, dexamethasone, ibuprofen, paracetamol, penicillin, and salbutamol, among others.
Manufacturing, distribution and marketing companies that participate in the production chain of these inputs were ordered to increase production, distribution and marketing to the maximum of their installed capacity and to arbitrate the means to ensure distribution and supply to the population and health entities. Likewise, companies were also ordered to report every five days the quantity of goods produced and marketed, the recipients of said sales operations and their production plan for the following three months.
Finally, marketing and distribution companies of critical supplies were ordered to give priority to the acquisition of those supplied by health entities.
By Resolution 681/2020 of the Ministry of Health, published on March 31, 2020, pharmacies with authorized laboratories allowed to manufacture and stock up to five kilograms of gel alcohol in order to rationally respond to sales needs during the health emergency period. The provisions are applicable in the City of Buenos Aires, other jurisdictions being invited to adhere to the measure.
By Resolution 695/2020 of the Ministry of Health, published on April 1st 2020, it was established that the companies that manufacture, distribute or commercialize invasive mechanical ventilators shall not deliver units without obtaining prior and express authorization from the Ministry of Health, regardless of the existence of a purchase order, contract or obligation of any nature that they may have previously agreed to. The measure is aimed at avoiding inequalities in the distribution of said equipment among the different regions of the country and guaranteeing a coordinated response from the Government, taking into account the epidemiological situation of each jurisdiction.
By Resolution 132/2020 of the Ministry of Productive Development, published on April 1st 2020, the program named "SUPPORT TO THE NATIONAL PRODUCTIVE SYSTEM IN THE AREA OF MEDICAL EQUIPMENT AND MEDICAL AND SANITARY SUPPLIES AND TECHNOLOGICAL SOLUTIONS IN THE FRAMEWORK OF THE CORONAVIRUS COVID-19 PANDEMIC " (the "Program") was created, with the aim of assisting and financing the public health sector and companies, entrepreneurs and public institutions within the framework of the health emergency.
The direct beneficiaries of the Program are the companies, suppliers of their productive value chain, entrepreneurs, public institutions and other productive units that make contributions in the area of medical equipment and sanitary and medial inputs, as well as technological solutions and their developments and implementation that help in the prevention, diagnosis, treatment, monitoring, control and/or other aspects related to the COVID-19.
For further information of the actions prescribed by the Program, please refer to Annex I of the Resolution available (only in Spanish) here.
Resolutions 17 and 18/2020
Resolution 17/2020 issued by the National Institute of Viticulture (INV) and published on April 3rd, 2020, established that –on an exceptional and transitory basis and for the duration of the emergency- ethyl alcohol that is banned for use in the wine industry due to violations of the legal regime established by Law 24,566 (National Alcohol Law) and its regulations will be primarily directed to help combat the emergency linked to the COVID-19 pandemic, once the analytical stage of the proceedings opened as a consequence of such violations is closed, in accordance with the provisions of Resolution No. C.40 dated September 30, 1991.
Likewise, by Resolution 18/2020 of the INV published on April 3rd, 2020 it was also established that those products that are permanently identified as "GENUINE PRODUCT - DAMAGED " and/or "DOES NOT CORRESPOND TO ITS ORIGIN ANALYSIS " in accordance with Sections 23 Subsection b) and 24 Subsection b) of Law No. 14.878 (General Law of Wines), respectively, that are banned in bulk in wine establishments registered with the INV once the analytical stage of the proceedings opened as a consequence of such violations is closed, as well as the products banned in accordance with Resolution 15/2020 of the INV, will have as a priority destination their distillation to combat the referred to emergency.
Those interested in participating in these schemes must appear before the INV unit of their jurisdiction in order to process their request and indicate the final destination of the product. Final beneficiaries must be a national, provincial or municipal public entity or private health entity authorized by the INV.